Bruker's Q2 Revenues Rise 33 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bruker today reported a 33 percent increase year over year in revenues for the second quarter with its Scientific Instruments division also growing 33 percent.

For the three months ended June 30, the company posted $401.2 million in revenues, up from $300.9 million a year ago, surpassing analysts' forecasts of $384.1 million. The firm said that on a currency-adjusted basis, revenues grew 21 percent year over year, corresponding to organic growth of 8 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.